{"id":"estradiol-transdermal-product","safety":{"commonSideEffects":[{"rate":"10%","effect":"Vaginal bleeding"},{"rate":"20%","effect":"Breast tenderness"},{"rate":"15%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Estradiol acts as an estrogen receptor agonist, binding to estrogen receptors and activating them, which leads to various physiological effects.","oneSentence":"Estrogen receptor agonist","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:52:01.243Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of estrogen deficiency symptoms"},{"name":"Prevention of osteoporosis"}]},"trialDetails":[{"nctId":"NCT07466498","phase":"PHASE2","title":"Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Washington","startDate":"2026-08-01","conditions":"Castration-Sensitive Prostate Adenocarcinoma, Metastatic Castration-Sensitive Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8","enrollment":60},{"nctId":"NCT07032506","phase":"NA","title":"Intrauterine Stent Placement Following Hysteroscopic Septum Resection","status":"NOT_YET_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2026-03","conditions":"Intrauterine Adhesion","enrollment":320},{"nctId":"NCT06497894","phase":"PHASE4","title":"No More Sleepless Nights in Perimenopause","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2026-01-01","conditions":"Insomnia, Menopause","enrollment":54},{"nctId":"NCT04265053","phase":"EARLY_PHASE1","title":"Human Cerebral Blood Flow Regulation","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2021-04-12","conditions":"Cerebral Arterial Diseases","enrollment":110},{"nctId":"NCT06306404","phase":"PHASE4","title":"Sleeping Through Menopause","status":"NOT_YET_RECRUITING","sponsor":"VU University of Amsterdam","startDate":"2025-10-01","conditions":"Menopause, Insomnia","enrollment":222},{"nctId":"NCT04833140","phase":"PHASE3","title":"Estrogen Administration for the Treatment of NASH in Postmenopausal Women","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-12-02","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":60},{"nctId":"NCT03018366","phase":"PHASE2","title":"Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2017-01-01","conditions":"Estrogen Deficiency, Cardiovascular Disease (CVD), Functional Hypothalamic Amenorrhea","enrollment":29},{"nctId":"NCT06715514","phase":"NA","title":"Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes","status":"RECRUITING","sponsor":"Lia Bally","startDate":"2025-02-18","conditions":"Menopause, Type 2 Diabetes","enrollment":96},{"nctId":"NCT06570460","phase":"PHASE4","title":"Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2021-11-29","conditions":"Turner Syndrome, Hypogonadism; Ovarian, Hormone Replacement Therapy","enrollment":50},{"nctId":"NCT06544473","phase":"PHASE4","title":"Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2021-11-29","conditions":"Turner Syndrome, Hypogonadism; Ovarian, Hormone Replacement Therapy","enrollment":50},{"nctId":"NCT06264882","phase":"PHASE4","title":"Cardiometabolic Consequences of the Loss of Ovarian Function","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2024-06-01","conditions":"Menopause, Estrogen Deficiency, Aging","enrollment":100},{"nctId":"NCT05802303","phase":"NA","title":"Estrogen (Gel)Transdermal vs Oral Estrogen for Endometrial Preparation","status":"TERMINATED","sponsor":"Indira IVF Hospital Pvt Ltd","startDate":"2023-07-25","conditions":"Frozen Embryo Transfer, Infertility, Female","enrollment":172},{"nctId":"NCT04043520","phase":"PHASE4","title":"Bioenergetic Effects of Aging and Menopause (BEAM)","status":"UNKNOWN","sponsor":"University of Colorado, Denver","startDate":"2019-09-24","conditions":"Menopause, Obesity, Abdominal, Aging","enrollment":57},{"nctId":"NCT05678192","phase":"PHASE1","title":"Effect of Menopausal Hormone Therapy on Immune System Parameters","status":"COMPLETED","sponsor":"Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare","startDate":"2021-12-01","conditions":"Last Period Not Earlier Than 6 Months Ago","enrollment":40},{"nctId":"NCT00268476","phase":"PHASE2, PHASE3","title":"Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical Research Council","startDate":"2005-07-08","conditions":"Prostate Cancer","enrollment":11992},{"nctId":"NCT00413764","phase":"PHASE3","title":"Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-03-23","conditions":"Sexual Dysfunction","enrollment":358},{"nctId":"NCT02367833","phase":"PHASE4","title":"Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis","status":"COMPLETED","sponsor":"Penn State University","startDate":"2015-01","conditions":"Bone; Disorder, Development and Growth","enrollment":60},{"nctId":"NCT03868202","phase":"PHASE2","title":"Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of Estradiol","status":"UNKNOWN","sponsor":"Eastern Virginia Medical School","startDate":"2019-07-03","conditions":"Follicle Stimulating Hormone Glycosylation, Urinary FSH21/FSH24 Ratio, Estradiol Effect","enrollment":10},{"nctId":"NCT02922348","phase":"PHASE3","title":"Hormone Replacement for Premature Ovarian Insufficiency","status":"WITHDRAWN","sponsor":"University of Pennsylvania","startDate":"2016-03-01","conditions":"Primary Ovarian Insufficiency","enrollment":""},{"nctId":"NCT03921736","phase":"PHASE4","title":"Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.","status":"COMPLETED","sponsor":"Anna Posadzy-Małaczyńska","startDate":"2000-01-10","conditions":"Hypertension, Hyperuricemia, Menopause","enrollment":180},{"nctId":"NCT03155048","phase":"NA","title":"The Effects of Estrogen on Artificial Endometrium","status":"COMPLETED","sponsor":"Memorial Sisli Hospital, Istanbul","startDate":"2017-05-01","conditions":"Infertility","enrollment":317},{"nctId":"NCT00066157","phase":"PHASE2, PHASE3","title":"Alzheimer's Disease: Therapeutic Potential of Estrogen","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2001-09","conditions":"Alzheimer Disease","enrollment":42},{"nctId":"NCT01250210","phase":"PHASE2","title":"Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control","status":"COMPLETED","sponsor":"Agile Therapeutics","startDate":"2007-09","conditions":"Ovulation Suppression","enrollment":123},{"nctId":"NCT01181479","phase":"PHASE3","title":"Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System","status":"COMPLETED","sponsor":"Agile Therapeutics","startDate":"2010-08","conditions":"Contraception","enrollment":1504},{"nctId":"NCT01243580","phase":"PHASE1","title":"AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol","status":"COMPLETED","sponsor":"Agile Therapeutics","startDate":"2009-08","conditions":"Healthy","enrollment":36},{"nctId":"NCT00701337","phase":"PHASE4","title":"Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2006-09","conditions":"Postmenopausal","enrollment":40},{"nctId":"NCT00459810","phase":"PHASE2","title":"Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2007-02","conditions":"Prostate Cancer","enrollment":21},{"nctId":"NCT01546454","phase":"NA","title":"Relationship Between the Menstrual Cycle and Heart Disease in Women","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2012-02","conditions":"Coronary Heart Disease","enrollment":5},{"nctId":"NCT00377988","phase":"","title":"A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2002-04","conditions":"Contraception, Female Contraception","enrollment":423},{"nctId":"NCT00331071","phase":"","title":"Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2002-04","conditions":"Contraception, Female Contraception","enrollment":334},{"nctId":"NCT00586898","phase":"PHASE2","title":"Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2001-07","conditions":"Prostate, Cancer, Hormonal Cycling","enrollment":36},{"nctId":"NCT00933179","phase":"PHASE2","title":"FC Patch Low: Metabolism Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-06","conditions":"Contraception","enrollment":30},{"nctId":"NCT02264743","phase":"PHASE4","title":"Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy","status":"UNKNOWN","sponsor":"Royal Brompton & Harefield NHS Foundation Trust","startDate":"2013-11","conditions":"Venous Thrombosis, Insulin Resistance","enrollment":60},{"nctId":"NCT00224094","phase":"PHASE4","title":"A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2002-01","conditions":"Menopause","enrollment":27},{"nctId":"NCT00732693","phase":"PHASE4","title":"Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2002-02","conditions":"Premature Ovarian Failure","enrollment":42},{"nctId":"NCT00554632","phase":"NA","title":"Birth Control Pill vs Birth Control Patch Study","status":"COMPLETED","sponsor":"University of Vermont","startDate":"2003-04","conditions":"Venous Thrombosis","enrollment":24},{"nctId":"NCT00204074","phase":"PHASE2, PHASE3","title":"Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.","status":"UNKNOWN","sponsor":"University Hospital, Linkoeping","startDate":"2001-10","conditions":"Migraine","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Micronized progesterone"],"phase":"phase_2","status":"active","brandName":"Estradiol Transdermal Product","genericName":"Estradiol Transdermal Product","companyName":"Eastern Virginia Medical School","companyId":"eastern-virginia-medical-school","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Estrogen receptor agonist Used for Treatment of estrogen deficiency symptoms, Prevention of osteoporosis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}